"Trends in Wellness Investments", David T. Thibodeau, Managing Director, Wellvest Capital
P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
Synthetic Biology Workshop 2017 - Panel Discussion
Max Kanter, Cofounder & CEO, Feature Labs
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
Natalya Baily, CEO & Cofounder, Accion
Charles Fracchia, Founder, BioBright
Lightning Talks featuring startups: Enbiotix, Ginkgo Bioworks, ManusBio, Glympse Bio, BioDevek, Asimov, and BioBuilder.
Rei Goffer, Cofounder & Chief Strategy Officer, ClimaCell
Chazz Sims, Founder, Wise Systems